Drug Shortage Report for PMS-DICLOFENAC-MISOPROSTOL
| Report ID | 83735 |
| Drug Identification Number | 02413469 |
| Brand name | PMS-DICLOFENAC-MISOPROSTOL |
| Common or Proper name | DICLOFENAC-MISOPROST |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MISOPROSTOL DICLOFENAC SODIUM |
| Strength(s) | 200MCG 50MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 250 |
| ATC code | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-06-25 |
| Actual start date | 2019-07-30 |
| Estimated end date | 2021-01-27 |
| Actual end date | 2021-01-31 |
| Shortage status | Resolved |
| Updated date | 2021-02-01 |
| Company comments | Product available in AB, BC, QC, MB, NS, PEI, NL, SK and NB. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-05-09 | English | Compare |